| Emerging applications of exosomes in cancer therapeutics and diagnostics S Inamdar, R Nitiyanandan, K Rege Bioengineering & translational medicine 2 (1), 70-80, 2017 | 75 | 2017 |
| Chemomechanically engineered 3D organotypic platforms of bladder cancer dormancy and reactivation TSP Grandhi, T Potta, R Nitiyanandan, I Deshpande, K Rege Biomaterials 142, 171-185, 2017 | 39 | 2017 |
| Copper-eluting fibers for enhanced tissue sealing and repair D Ghosh, S Godeshala, R Nitiyanandan, MS Islam, JR Yaron, D DiCaudo, ... ACS applied materials & interfaces 12 (25), 27951-27960, 2020 | 25* | 2020 |
| Folate receptor‐targeted aminoglycoside‐derived polymers for transgene expression in cancer cells S Godeshala, R Nitiyanandan, B Thompson, S Goklany, DR Nielsen, ... Bioengineering & Translational Medicine 1 (2), 220-231, 2016 | 18 | 2016 |
| An inhibitor screen identifies histone-modifying enzymes as mediators of polymer-mediated transgene expression from plasmid DNA MD Christensen, R Nitiyanandan, S Meraji, R Daer, S Godeshala, ... Journal of controlled release 286, 210-223, 2018 | 17 | 2018 |
| Light‐activated tissue‐integrating sutures as surgical nanodevices D Ghosh, R Urie, A Chang, R Nitiyanandan, JK Lee, J Kilbourne, K Rege Advanced healthcare materials 8 (14), 1900084, 2019 | 16 | 2019 |
| Handbook of materials for nanomedicine V Torchilin, MM Amiji Pan Stanford Publishing, 2011 | 16 | 2011 |
| Antimicrobial laser-activated sealants for combating surgical site infections R Urie, M McBride, D Ghosh, A Fattahi, R Nitiyanandan, J Popovich, ... Biomaterials science 9 (10), 3791-3803, 2021 | 13 | 2021 |
| Gut-derived Endotoxin-TLR4 Signaling Drives MYC-Ig Translocation to Promote Lymphoproliferation through c-JUN and STAT3 Activation A Rokan, JC Hernandez, R Nitiyanandan, ZY Lin, CL Chen, T Machida, ... Molecular Cancer Research 21 (2), 155-169, 2023 | 1 | 2023 |
| 3D cell cultures exhibit increased drug resistance, particularly to taxanes. C Maestri, J Kumar, R Nitiyanandan, I Trus, R Parker, B Apfel, C Apfel Journal of Clinical Oncology 42 (16_suppl), e12599-e12599, 2024 | | 2024 |
| Cell-cycle inhibition may influence differences in 2D vs 3D tumor sensitivity profiles J Kumar, C Maestri, R Nitiyanandan, I Trus, RJ Parker, B Apfel, C Apfel Cancer Research 84 (6_Supplement), 512-512, 2024 | | 2024 |
| Aminoglycoside antibiotic-derived microbead-encapsulated spheroids and methods of making and using the same K Rege, R Nitiyanandan, T Nanda US Patent 11,931,460, 2024 | | 2024 |
| A high-throughput multiplexed viability and proliferation assay RN Christian Apfel, Parthasarathy CHANDRAKESAN, Ricardo Jerome PARKER ... US Patent WO2023244699A1, 2023 | | 2023 |
| Dear Reader, Welcome to the final issue of Drugs—Real World Outcomes for 2022. UK Hamza Garashi, D García-Azorín, SC Gasteiger | | 2022 |
| Copper-Eluting Fibers for Enhanced Tissue Sealing and Repair (vol 12, pg 27951, 2020) D Ghosh, S Godeshala, R Nitiyanandan, MS Islam, JR Yaron, D DiCaudo, ... ACS APPLIED MATERIALS & INTERFACES 12 (47), 53568-53569, 2020 | | 2020 |
| Molecular Engineering of Aminoglycoside-Derived Hydrogel Platform for 3D Organoid Generation As a Cancer Dormancy Model R Nitiyanandan, S Goklany, S Dutta, K Rege 2020 Virtual AIChE Annual Meeting, 2020 | | 2020 |
| Synergistic Combinations Using APE1 Inhibitors for Ablation of Advanced Melanoma R Nitiyanandan, S Goklany, D Julien, D Ghosh, A Maltagliati, ... 2020 Virtual AIChE Annual Meeting, 2020 | | 2020 |
| Exosomes in Cancer Disease, Progression, and Drug Resistance TSP Grandhi, R Nitiyanandan, K Rege Handbook of Materials for Nanomedicine, 257-293, 2020 | | 2020 |
| Methods of treating cancer with the combination of granzyme a gene delivery and hsp90 inhibition K Rege, R Nitiyanandan US Patent App. 16/545,894, 2020 | | 2020 |
| Synergistic Combinations Using APE1 Inhibitors for Ablation of Advanced Melanoma Rajeshwar Nitiyanandan, Sudhakar Godeshala , Sheba Goklany, Daniel Julien ... AIChE Annual Meeting (ISBN: 978-0-8169-1114-1), 2020 | | 2020 |